-
DEFINING TREATMENT TOLERABILITY FROM THE PATIENT’S PERSPECTIVE: A MIXED-METHODS ANALYSIS OF THE CANCER EXPERIENCE REGISTRY
Mar 18, 2026, 21:38 PM -
SAFETY OF SEPIAPTERIN AND PEGVALIASE FOR THE TREATMENT OF PHENYLKETONURIA (PKU): A SIMULATED TREATMENT COMPARISON (STC)
Mar 18, 2026, 21:38 PM -
TURNING DATA INTO BUSINESS MODEL INNOVATION: A PRAGMATIC CRITICAL REALIST APPROACH TO THE EUROPEAN PARADOX IN A POST-MFN WORLD
Mar 18, 2026, 21:38 PM -
COST EFFECTIVENESS ANALYSIS OF OBINUTUZUMAB? VERSUS CYCLOSPORINE A IN THE TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF RSV MATERNAL IMMUNIZATION [RSVPREF] IN THE DOMINICAN REPUBLIC: A COST-UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
INCORPORATING REAL-WORLD EVIDENCE (RWE) USING A REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR) AUGMENTS TRADITIONAL SLRS: CASE STUDY IN NON-SMALL-CELL LUNG CANCER (NSCLC)
Mar 18, 2026, 21:38 PM -
POST HOC ANALYSIS OF PATIENT AND TREATMENT CHARACTERISTICS BY VONOPRAZAN TREATMENT DURATION: RESULTS FROM PATIENTS WITH REFLUX OESOPHAGITIS IN THE VIEW STUDY
Mar 18, 2026, 21:38 PM -
WHAT HEOR CAN LEARN FROM MATURE AI INDUSTRIES AND WHERE THE ANALOGIES BREAK DOWN
Mar 18, 2026, 21:38 PM -
IMPACT OF PD-1 AND PD-L1 INHIBITORS ON PATIENT-REPORTED OUTCOMES IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS
Mar 18, 2026, 21:38 PM -
COMPARATIVE ANALYSIS OF GENE THERAPIES AUTHORIZED BY THE U.S. FOOD AND DRUG ADMINISTRATION AND THE EUROPEAN MEDICINES AGENCY
Mar 18, 2026, 21:38 PM -
EXAMINATION OF PROTECTIVE AND RISK FACTORS DETERMINING THE PROFESSIONAL QUALITY OF LIFE OF PUBLIC HEALTH NURSES
Mar 18, 2026, 21:38 PM -
EFFECT OF ANTIHYPERTENSIVE USE ON FALL RISK
Mar 18, 2026, 21:38 PM -
BARRIERS TO HEALTHCARE USE AMONG ADOLESCENTS IN CONFLICT-AFFECTED IDP CAMPS IN NORTHEASTERN NIGERIA: REAL-WORLD EVIDENCE ON ACCESS, EQUITY, AND SERVICE DELIVERY COSTS
Mar 18, 2026, 21:38 PM -
INTERPRETABLE MACHINE LEARNING TO PREDICT CATASTROPHIC HEALTH EXPENDITURE RISK IN CHINA: EVIDENCE FROM NATIONALLY REPRESENTATIVE SURVEY DATA
Mar 18, 2026, 21:38 PM -
INCIDENCE AND RISK FACTORS FOR SEXUALLY TRANSMITTED DISEASES FOLLOWING SOLID ORGAN TRANSPLANT, HEMATOPOIETIC STEM CELL TRANSPLANTATION, AND CAR T-CELL THERAPY
Mar 18, 2026, 21:38 PM -
DIGITAL BIOMARKERS OF SLEEP, STRESS, AND MENTAL HEALTH IN YOUTH: A SCOPING REVIEW OF OURA RING-BASED EVIDENCE
Mar 18, 2026, 21:38 PM -
WHEN HYPERTENSION REACHES THE HOSPITAL: PROFILING PATIENTS ADMITTED WITH HYPERTENSION AS A PRIMARY DIAGNOSIS IN CHILE’S PUBLIC SECTOR
Mar 18, 2026, 21:38 PM -
CT RADIATION EXPOSURE AND DIAGNOSTIC REFERENCE LEVEL ADHERENCE ACROSS KUWAIT'S PUBLIC HOSPITALS: A FIVE-YEAR ANALYSIS OF 100K EXAMINATIONS
Mar 18, 2026, 21:38 PM -
BAYESIAN MULTI-PARAMETER EVIDENCE SYNTHESIS FOR INFORMED INDIRECT TREATMENT COMPARISONS OF EXTRAPOLATED SURVIVAL OUTCOMES
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH ADHERENCE TO OPIOID AGONIST THERAPY IN ONTARIO: A LONGITUDINAL POPULATION-BASED STUDY (2014-2022)
Mar 18, 2026, 21:38 PM
